Eskayef Pharmaceuticals Limited has completed the production of Remdisivir, the drug which is proved to be effective in treating COVID-19 patients.
After completion of all production process, the company started to distribute the drug on Friday, according to a media statement.
Remdesivir, a drug developed by Gilead Sciences in the US, has grabbed attention as one of the most promising treatments for Covid-19, the respiratory disease caused by the novel coronavirus that has killed more than 250,000 people.
It got the approval of US Food and Drug Administration (FDA) as a drug against coronavirus last week.
The brand name for Remdesivir manufactured by Eskayef is Remivir.